SCHEMBL7897307

SCHEMBL7897307

C[C@H](NS(=O)(=O)c1ccc(C(=O)O)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 1/20 0.47
TDP1 Q9NUW8 1/20 0.45
MMP13 P45452 2/20 0.45
MMP1 P03956 1/20 0.45
MMP2 P08253 1/20 0.45
MMP3 P08254 1/20 0.45
MMP7 P09237 1/20 0.45
MMP9 P14780 1/20 0.45
L3MBTL1 Q9Y468 4/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
ADAM17 P78536 1/20 0.42
F2 P00734 1/20 0.41
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
PRSS3 P35030 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL789823 0.87 ADAMTS4 (0.54) ADAMTS4MMP13MMP1MMP2MMP3
SCHEMBL28849866 0.85 ADAMTS4 (0.51) ADAMTS4TDP1MMP13MMP1MMP2
SCHEMBL1185524 0.84 MMP2 (0.50) ADAMTS4MMP13MMP1MMP2MMP3
SCHEMBL27465878 0.84 ALDH1A1 (0.50) ADAMTS4TDP1MMP13MMP1MMP2
SCHEMBL8445730 0.84 MMP2 (0.59) ADAMTS4MMP13MMP1MMP2MMP3
SCHEMBL1186251 0.84 MMP2 (0.50) ADAMTS4MMP13MMP1MMP2MMP3
SCHEMBL29540524 0.83 HSD17B10 (0.54) MMP13MMP1MMP2MMP3MMP7
SCHEMBL6796513 0.82 MMP13 (0.50) ADAMTS4MMP13MMP1MMP2MMP3
SCHEMBL7669662 0.81 MMP9 (0.62) MMP2MMP9L3MBTL1KMT2AMEN1
SCHEMBL7692231 0.81 TDP1 (0.49) ADAMTS4TDP1MMP13MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed